Showing results (1-10 of 91) with videos related to
Sort By:
Pageof 10
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|April 9, 2026
Lp(a): A potentially modifiable cardiovascular risk factorDaniel E Hilleman, James M BackesFuture Cardiology|March 1, 2021
New and emerging lipid-lowering therapyJames M Backes, Daniel E HillemanAmerican Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|September 19, 2024
A Clinicians Guide to Recommending Common Cholesterol-Lowering Dietary SupplementsJames M Backes, Daniel E HillemanFuture Cardiology|January 16, 2024
Lipid lowering therapy: implications of recent clinical trialsJames M Backes, Daniel E HillemanSouthern Medical Journal|April 3, 2024
Elevated Lp(a): Guidance for Identifying and Managing PatientsDaniel E Hilleman, James L Vacek, James M BackesPostgraduate Medicine|October 6, 2025
A narrative review of drugs targeting inflammation in vascular diseaseJenna Kristan, Mark A Malesker, James M Backes, et al.Pharmacotherapy|December 24, 2002
Comparison of gemfibrozil and fenofibrate in patients with dyslipidemic coronary heart diseaseKathleen A Packard, James M Backes, Thomas L Lenz, et al.Seminars in Thoracic and Cardiovascular Surgery|March 31, 2007
Cost considerations with tight glycemic control in the acute care settingDaniel E HillemanJournal of Clinical Lipidology|October 10, 2025
Assessing pharmacists' knowledge and practices involving dietary supplement omega-3 fatty acidsJames M Backes, Craig J Beavers, Dave L Dixon, et al.Pageof 10